Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity.
Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity. Molecules. 2023 Sep 15; 28(18).
View in:
PubMed
subject areas
Antiviral Agents
Benzamides
Humans
Ligands
Piperidines
Protease Inhibitors
Pyridines
Thiazoles
authors with profiles
Savas Tay